Evidence map›Paper›PMID 38095438›Full record

ReviewClinical microbiology reviews2024

Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond.

Michael D Parkins, Bonita E Lee, Nicole Acosta, Maria Bautista, Casey R J Hubert, Steve E Hrudey, Kevin Frankowski, Xiao-Li Pang

Open access · greenAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 2 pooled it
24.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 2 syntheses or guidelines pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. SiOMikrochimica acta · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Prospective use of wastewater surveillance for early detection of enterovirus D68 in community outbreaks among children, Niigata City, Japan, 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  20. Wastewater Treatment Challenges and Circular Reuse for One Health Sustainability: A Review.International journal of environmental research and public health · 2026
    Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michael D ParkinsDepartment of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-3749-7930
Bonita E LeeDepartment of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
Nicole AcostaDepartment of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
Maria BautistaDepartment of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
Casey R J HubertDepartment of Biological Sciences, Faculty of Science, University of Calgary, Calgary, Alberta, Canada.
Steve E HrudeyDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.
Kevin FrankowskiAdvancing Canadian Water Assets, University of Calgary, Calgary, Alberta, Canada.
Xiao-Li PangDepartment of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0002-5520-1083
University of Calgary · CAUniversity of Alberta · CAAlberta Health Services · CA

Funding

Alberta Health
6 · The paper itself

Abstract

Wastewater-based surveillance (WBS) has undergone dramatic advancement in the context of the coronavirus disease 2019 (COVID-19) pandemic. The power and potential of this platform technology were rapidly realized when it became evident that not only did WBS-measured SARS-CoV-2 RNA correlate strongly with COVID-19 clinical disease within monitored populations but also, in fact, it functioned as a leading indicator. Teams from across the globe rapidly innovated novel approaches by which wastewater could be collected from diverse sewersheds ranging from wastewater treatment plants (enabling community-level surveillance) to more granular locations including individual neighborhoods and high-risk buildings such as long-term care facilities (LTCF). Efficient processes enabled SARS-CoV-2 RNA extraction and concentration from the highly dilute wastewater matrix. Molecular and genomic tools to identify, quantify, and characterize SARS-CoV-2 and its various variants were adapted from clinical programs and applied to these mixed environmental systems. Novel data-sharing tools allowed this information to be mobilized and made immediately available to public health and government decision-makers and even the public, enabling evidence-informed decision-making based on local disease dynamics. WBS has since been recognized as a tool of transformative potential, providing near-real-time cost-effective, objective, comprehensive, and inclusive data on the changing prevalence of measured analytes across space and time in populations. However, as a consequence of rapid innovation from hundreds of teams simultaneously, tremendous heterogeneity currently exists in the SARS-CoV-2 WBS literature. This manuscript provides a state-of-the-art review of WBS as established with SARS-CoV-2 and details the current work underway expanding its scope to other infectious disease targets.

Indexed as

COVID-19SARS-CoV-2HumansRNA, ViralWastewaterWastewater-Based Epidemiological MonitoringRNA, ViralWastewaterantimicrobial resistanceCOVID-19poliosewagewastewaterwastewater-based epidemiology

Identifiers

PMID38095438
PMCPMC10938902
OpenAlexW4389732744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.